Hydroxyproline-containing collagen analogs trigger the release and activation of collagen-sequestered proMMP-2 by competition with prodomain-derived peptide P33-42
2011

Collagen Analogs Activate ProMMP-2 in Liver Fibrosis

publication Evidence: moderate

Author Information

Author(s): Ruehl Martin, Muche Marion, Freise Christian, Erben Ulrike, Neumann Ulf, Schuppan Detlef, Popov Yury, Dieterich Walburga, Zeitz Martin, Farndale Richard W, Somasundaram Rajan

Primary Institution: Charité, Campus Benjamin Franklin, Berlin, Germany

Hypothesis

Can synthetic collagen analogs modulate the activity of proMMP-2 and proMMP-9 in liver fibrosis?

Conclusion

Collagen analogs can effectively release and activate proMMP-2 and proMMP-9, suggesting potential therapeutic strategies for liver fibrosis.

Supporting Evidence

  • ProMMP-2 and proMMP-9 bind strongly to collagen structures.
  • Synthetic collagen analogs can displace proMMPs from collagen, leading to their activation.
  • The study suggests that collagen analogs may be used to treat liver fibrosis.

Takeaway

This study shows that special collagen-like substances can help activate certain proteins that break down scar tissue in the liver.

Methodology

The study used in situ zymography, immunohistology, solid-phase binding studies, and surface plasmon resonance to analyze the interactions between collagen analogs and MMPs.

Limitations

The study primarily focuses on in vitro findings, which may not fully translate to in vivo conditions.

Digital Object Identifier (DOI)

10.1186/1755-1536-4-1

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication